logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Sarepta Pharmaceuticals Jumps on Competitor’s Failure

  +Follow August 16, 2013 9:54AM
Share:
Tickers Mentioned:

Sarepta Therapeutics Inc. (SRPT) experienced a bit of schadenfreude on Aug. 16 as a direct competitor stumbled badly at the finish line.

Competitor GlaxoSmithKline plc (GSK) had been neck-and-neck with Serepta in the race to develop a breakthrough muscle disorder drug to treat Duchenne Muscular Dystrophy. Both drugs were far ahead of the pack in the development process.

That is, until Baird analyst Brian Skorney reported that Glaxo’s drug, drisapersen, has encountered major stumbling blocks on several fronts that could significantly hamper development. Skorney cited clinical, regulatory, and commercials issues with the drug. Most importantly, the drug did not seem to effectively treat symptoms of the disease at the targeted dose.

Serepta’s drug, eteplirsen, so far has seemed to be effective at treating symptoms of Duchenne. Clinical trials have taken place in the UK. On Aug. 7 the company released promising clinical trial information, which will form the basis of their application for US FDA approval in early 2014.

Duchenne is a severely debilitating form of muscular dystrophy. The recessive muscular degenerative disorder affects approximately 1 in 3,600 boys, and life expectancy for sufferers is usually around 25. A drug from either company would be the first on the American market designed to treat the disorder.

The London-based GlaxoSmithKline , which is the fourth largest pharmaceutical company in the world, shrugged off the setback. Their stock is up .33 percent to hit $51.70 a share.

Serepta is up 6.77 percent to hit $34.21 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Signup for our daily newsletter and get our best articles emailed right to you!

Results for GSK
Stockaholics
22 Nov 14 13:19:12
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $LFAP $GSK $ROX
Daniel Ward
22 Nov 14 12:52:31
$CLSN Buyout Offer On The Table.." http://t.co/zpYFTf4W9h" Sierra Equity is The Onion of biotech, said $GSK buying $AEZS last week
Stockaholics
21 Nov 14 23:42:17
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $LFAP $GSK $ROX
Stockaholics
21 Nov 14 16:00:19
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $LFAP $GSK $ROX
Quantheta
21 Nov 14 15:00:04
#SENTISHIFTUP $TNA $AKAM $GSK $CAT $DIA $FSLR $VSR $EBAY $GE $UGAZ #quantheta #sentiquant
Dieter Laevers
21 Nov 14 14:14:04
RT @pharmalot: Pharmalot.. Pharmalittle.. The Weekend Nears... headlines & weekend daydreams are here.. http://t.co/v2YC2clW2s #pharma #ebo…
US Banking News
21 Nov 14 14:12:57
Liberum Capital Reaffirms Sell Rating for GlaxoSmithKline plc $GSK http://t.co/I0kzrOjm1c
InterCooler
21 Nov 14 13:35:06
GlaxoSmithKline plc Receives Sell Rating from Liberum Capital $GSK http://t.co/u5o01RLXwv
US Consumer News
21 Nov 14 13:14:54
GlaxoSmithKline plc (ADR)'s sell rating reiterated at Liberum Capital. http://t.co/TelM04uw3D $GSK #GSK
Analyst Ratings
21 Nov 14 13:04:41
GlaxoSmithKline plc (ADR)'s sell rating reiterated at Liberum Capital. http://t.co/C28Aok9bQO $GSK #GSK
Quantheta
21 Nov 14 13:00:04
#SENTISHIFTUP $TNA $AKAM $GSK $CAT $FSLR $DIA $GE $EBAY $NEWS $VSR #quantheta #sentiquant
US Banking News
21 Nov 14 12:58:07
GlaxoSmithKline plc Stock Rating Reaffirmed by Liberum Capital $GSK http://t.co/FDnm6eY8aV
christii15
21 Nov 14 11:35:42
RT @BioRunner59: @christi7157 Yea they're n great position bc even co's that arent considered hcv players could instantly become relevant a…
BioRunner59
21 Nov 14 11:33:34
@christi7157 Yea they're n great position bc even co's that arent considered hcv players could instantly become relevant again $gsk $nvs etc
Todd King
21 Nov 14 11:20:41
RT @green_day4me: Epanova = no show. Lovaza = "lame duck" as $GSK tries to dump it from their portfolio. Generics sell LDL increasing drug.…
Market Int Center
21 Nov 14 11:19:54
GlaxoSmithKline PLC $GSK Showing Resistance Near $46.69 ( http://t.co/bMlxvMfSJc )
Samuel Brown
21 Nov 14 11:01:01
$GSK GlaxoSmithKline (GSK) Tops Access To Medicine Index http://t.co/TbBUn8Hid6
Quantheta
21 Nov 14 11:00:05
#SENTISHIFTUP $AKAM $TNA $GSK $CAT $VSR $DIA $GE $WMT $NEWS $EBAY #quantheta #sentiquant
Stockaholics
21 Nov 14 10:08:35
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $LFAP $GSK $ROX
Ticker Report
21 Nov 14 09:29:55
GlaxoSmithKline plc Rating Reiterated by Credit Suisse $GSK http://t.co/DsfSKiybIf
Seeking Alpha - All
21 Nov 14 09:21:52
Pfizer/Merck KGaA Immune Checkpoint Deal Bodes Extremely Well For Compugen http://t.co/b8BQLPqlmG $AZN $BMY $GSK $MRK $NVS $PFE $CGEN
greenday
21 Nov 14 09:20:41
Epanova = no show. Lovaza = "lame duck" as $GSK tries to dump it from their portfolio. Generics sell LDL increasing drug. $AMRN > mkt share
Jack Trader
21 Nov 14 09:01:55
$GSK GlaxoSmithKline (GSK) Tops Access To Medicine Index http://t.co/avoHNvoxex
Quantheta
21 Nov 14 09:00:04
#SENTISHIFTUP $AKAM $FSLR $TNA $VSR $GSK $CAT $DIA $WMT $GE $EBAY #quantheta #sentiquant
Georgia McCollum
21 Nov 14 07:54:17
MT @pharmalot: Pharmalot.. Pharmalittle.. The Weekend Nears... headlines & weekend daydreams http://t.co/V2AQiioTCC #pharma #ebola $MRK $GSK
Quantheta
21 Nov 14 07:00:06
#TOPTICKERTWEETS $SPY $AAPL $QQQ $DIA $EWJ $CAT $EBAY $BABA $AKAM $GSK #quantheta #sentiquant
Quantheta
21 Nov 14 07:00:05
#SENTISHIFTUP $AKAM $TNA $CAT $GE $CELG $GSK $CYTX $DIA $EBAY $SLV #quantheta #sentiquant
JVD
21 Nov 14 06:11:48
RT @pharmalot: Pharmalot.. Pharmalittle.. The Weekend Nears... headlines & weekend daydreams are here.. http://t.co/v2YC2clW2s #pharma #ebo…
manav sahay
21 Nov 14 06:11:18
RT @pharmalot: Pharmalot.. Pharmalittle.. The Weekend Nears... headlines & weekend daydreams are here.. http://t.co/v2YC2clW2s #pharma #ebo…
Stefanie Ilgenfritz
21 Nov 14 06:10:47
RT @pharmalot: Pharmalot.. Pharmalittle.. The Weekend Nears... headlines & weekend daydreams are here.. http://t.co/v2YC2clW2s #pharma #ebo…
WSJ Health News
21 Nov 14 06:10:47
RT @pharmalot: Pharmalot.. Pharmalittle.. The Weekend Nears... headlines & weekend daydreams are here.. http://t.co/v2YC2clW2s #pharma #ebo…
Kylie
21 Nov 14 05:59:08
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
Social Alpha Inc
21 Nov 14 05:58:36
Hottest stocks on social media now: $GSK $AKAM $CAT $HIBB $COM:YM $EBAY. Trade on market sentiment @ http://t.co/19bUOcsnYu #trading #stocks
Girls Unite 4 A Purp
21 Nov 14 05:57:50
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
Grant Brennecke
21 Nov 14 05:57:14
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
8 Balls
21 Nov 14 05:57:05
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
Estone Owen
21 Nov 14 05:56:19
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
1585
21 Nov 14 05:55:24
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
laura simms
21 Nov 14 05:54:17
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
Dusty Field
21 Nov 14 05:53:09
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
Wendie Lubic
21 Nov 14 05:52:59
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
Mary Anne Daly
21 Nov 14 05:52:37
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
MJE
21 Nov 14 05:52:26
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
Celtic Quest
21 Nov 14 05:51:43
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
SWRPD
21 Nov 14 05:51:25
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
Barbara Moon
21 Nov 14 05:50:47
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
Bruce Dorris
21 Nov 14 05:50:24
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
Mr. Ebola
21 Nov 14 05:50:16
RT @pharmalot: Pharmalot.. Pharmalittle.. The Weekend Nears... headlines & weekend daydreams are here.. http://t.co/v2YC2clW2s #pharma #ebo…
TriForceGameMaster
21 Nov 14 05:48:44
RT @philstockworld: Trouble at the Top for the Market and Our Top Trade Review: $DIA $SPY $AKAM $EBAY $GSK $HOV $CAT #TopTrades -- http://t…
pharmalot
21 Nov 14 05:48:43
Pharmalot.. Pharmalittle.. The Weekend Nears... headlines & weekend daydreams are here.. http://t.co/v2YC2clW2s #pharma #ebola $MRK $GSK
				
				
  +Follow August 16, 2013 9:54AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.